Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Pharmaceutical Intermediates Market Research Report 2026
Global Pharmaceutical Intermediates Market Research Report 2026
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Intermediates Market Size(US$)
CAGR 2026-2032
6.3%
Market Size,2032
USD 331,190
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 229,550 million
Market Forecast in 2032(Value)
US$ 331,190 million
CAGR
6.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Intermediates competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
This report delivers a comprehensive overview of the global Pharmaceutical Intermediates market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Intermediates. The Pharmaceutical Intermediates market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Intermediates market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Intermediates manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- GMP
- Non-GMP
Segment by Application
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Intermediates manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pharmaceutical Intermediates sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Pharmaceutical Intermediates Market Overview
1.1 Product Definition
1.2 Pharmaceutical Intermediates by Type
1.2.1 Global Pharmaceutical Intermediates Market Value by Type: 2025 vs 2032
1.2.2 GMP
1.2.3 Non-GMP
1.3 Pharmaceutical Intermediates by Application
1.3.1 Global Pharmaceutical Intermediates Market Value by Application: 2025 vs 2032
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Intermediates Revenue 2021–2032
1.4.2 Global Pharmaceutical Intermediates Sales 2021–2032
1.4.3 Global Pharmaceutical Intermediates Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pharmaceutical Intermediates Market Competition by Manufacturers
2.1 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pharmaceutical Intermediates Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pharmaceutical Intermediates, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Intermediates, Product Types and Applications
2.7 Global Key Manufacturers of Pharmaceutical Intermediates, Date of Entry into the Industry
2.8 Global Pharmaceutical Intermediates Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Intermediates Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pharmaceutical Intermediates Players Market Share by Revenue
2.8.3 Global Pharmaceutical Intermediates Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Intermediates Market Scenario by Region
3.1 Global Pharmaceutical Intermediates Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pharmaceutical Intermediates Sales by Region: 2021–2032
3.2.1 Global Pharmaceutical Intermediates Sales by Region: 2021–2026
3.2.2 Global Pharmaceutical Intermediates Sales by Region: 2027–2032
3.3 Global Pharmaceutical Intermediates Revenue by Region: 2021–2032
3.3.1 Global Pharmaceutical Intermediates Revenue by Region: 2021–2026
3.3.2 Global Pharmaceutical Intermediates Revenue by Region: 2027–2032
3.4 North America Pharmaceutical Intermediates Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pharmaceutical Intermediates Sales by Country (2021–2032)
3.4.3 North America Pharmaceutical Intermediates Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pharmaceutical Intermediates Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pharmaceutical Intermediates Sales by Country (2021–2032)
3.5.3 Europe Pharmaceutical Intermediates Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Intermediates Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pharmaceutical Intermediates Sales by Region (2021–2032)
3.6.3 Asia Pacific Pharmaceutical Intermediates Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Intermediates Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pharmaceutical Intermediates Sales by Country (2021–2032)
3.7.3 Latin America Pharmaceutical Intermediates Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Intermediates Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Intermediates Sales by Type (2021–2032)
4.1.1 Global Pharmaceutical Intermediates Sales by Type (2021–2026)
4.1.2 Global Pharmaceutical Intermediates Sales by Type (2027–2032)
4.1.3 Global Pharmaceutical Intermediates Sales Market Share by Type (2021–2032)
4.2 Global Pharmaceutical Intermediates Revenue by Type (2021–2032)
4.2.1 Global Pharmaceutical Intermediates Revenue by Type (2021–2026)
4.2.2 Global Pharmaceutical Intermediates Revenue by Type (2027–2032)
4.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2021–2032)
4.3 Global Pharmaceutical Intermediates Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pharmaceutical Intermediates Sales by Application (2021–2032)
5.1.1 Global Pharmaceutical Intermediates Sales by Application (2021–2026)
5.1.2 Global Pharmaceutical Intermediates Sales by Application (2027–2032)
5.1.3 Global Pharmaceutical Intermediates Sales Market Share by Application (2021–2032)
5.2 Global Pharmaceutical Intermediates Revenue by Application (2021–2032)
5.2.1 Global Pharmaceutical Intermediates Revenue by Application (2021–2026)
5.2.2 Global Pharmaceutical Intermediates Revenue by Application (2027–2032)
5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2021–2032)
5.3 Global Pharmaceutical Intermediates Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Company Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Lonza Pharmaceutical Intermediates Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Company Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Catalent Pharmaceutical Intermediates Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 Patheon
6.3.1 Patheon Company Information
6.3.2 Patheon Description and Business Overview
6.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Patheon Pharmaceutical Intermediates Product Portfolio
6.3.5 Patheon Recent Developments/Updates
6.4 Jubilant
6.4.1 Jubilant Company Information
6.4.2 Jubilant Description and Business Overview
6.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jubilant Pharmaceutical Intermediates Product Portfolio
6.4.5 Jubilant Recent Developments/Updates
6.5 Granules
6.5.1 Granules Company Information
6.5.2 Granules Description and Business Overview
6.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Granules Pharmaceutical Intermediates Product Portfolio
6.5.5 Granules Recent Developments/Updates
6.6 Ganesh
6.6.1 Ganesh Company Information
6.6.2 Ganesh Description and Business Overview
6.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ganesh Pharmaceutical Intermediates Product Portfolio
6.6.5 Ganesh Recent Developments/Updates
6.7 Chemcon
6.7.1 Chemcon Company Information
6.7.2 Chemcon Description and Business Overview
6.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chemcon Pharmaceutical Intermediates Product Portfolio
6.7.5 Chemcon Recent Developments/Updates
6.8 BASF
6.8.1 BASF Company Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BASF Pharmaceutical Intermediates Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Porton
6.9.1 Porton Company Information
6.9.2 Porton Description and Business Overview
6.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Porton Pharmaceutical Intermediates Product Portfolio
6.9.5 Porton Recent Developments/Updates
6.10 Lianhetech
6.10.1 Lianhetech Company Information
6.10.2 Lianhetech Description and Business Overview
6.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lianhetech Pharmaceutical Intermediates Product Portfolio
6.10.5 Lianhetech Recent Developments/Updates
6.11 ABA Chem
6.11.1 ABA Chem Company Information
6.11.2 ABA Chem Description and Business Overview
6.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 ABA Chem Pharmaceutical Intermediates Product Portfolio
6.11.5 ABA Chem Recent Developments/Updates
6.12 Tianma
6.12.1 Tianma Company Information
6.12.2 Tianma Description and Business Overview
6.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Tianma Pharmaceutical Intermediates Product Portfolio
6.12.5 Tianma Recent Developments/Updates
6.13 Jiujiujiu
6.13.1 Jiujiujiu Company Information
6.13.2 Jiujiujiu Description and Business Overview
6.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Jiujiujiu Pharmaceutical Intermediates Product Portfolio
6.13.5 Jiujiujiu Recent Developments/Updates
6.14 Alpha
6.14.1 Alpha Company Information
6.14.2 Alpha Description and Business Overview
6.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Alpha Pharmaceutical Intermediates Product Portfolio
6.14.5 Alpha Recent Developments/Updates
6.15 Jiuzhou
6.15.1 Jiuzhou Company Information
6.15.2 Jiuzhou Description and Business Overview
6.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Jiuzhou Pharmaceutical Intermediates Product Portfolio
6.15.5 Jiuzhou Recent Developments/Updates
6.16 Yongtai
6.16.1 Yongtai Company Information
6.16.2 Yongtai Description and Business Overview
6.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Yongtai Pharmaceutical Intermediates Product Portfolio
6.16.5 Yongtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Intermediates Industry Chain Analysis
7.2 Pharmaceutical Intermediates Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Intermediates Production Mode & Process Analysis
7.4 Pharmaceutical Intermediates Sales and Marketing
7.4.1 Pharmaceutical Intermediates Sales Channels
7.4.2 Pharmaceutical Intermediates Distributors
7.5 Pharmaceutical Intermediates Customer Analysis
8 Pharmaceutical Intermediates Market Dynamics
8.1 Pharmaceutical Intermediates Industry Trends
8.2 Pharmaceutical Intermediates Market Drivers
8.3 Pharmaceutical Intermediates Market Challenges
8.4 Pharmaceutical Intermediates Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Intermediates Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pharmaceutical Intermediates Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Pharmaceutical Intermediates Market Competitive Situation by Manufacturers in 2025
Table 4. Global Pharmaceutical Intermediates Sales (K MT) of Key Manufacturers (2021–2026)
Table 5. Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Pharmaceutical Intermediates Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Pharmaceutical Intermediates Average Price (USD/MT) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Pharmaceutical Intermediates, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Intermediates, Product Types and Applications
Table 12. Global Key Manufacturers of Pharmaceutical Intermediates, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Intermediates Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Intermediates Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Intermediates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Pharmaceutical Intermediates Sales by Region (K MT), 2021–2026
Table 18. Global Pharmaceutical Intermediates Sales Market Share by Region (2021–2026)
Table 19. Global Pharmaceutical Intermediates Sales by Region (K MT), 2027–2032
Table 20. Global Pharmaceutical Intermediates Sales Market Share by Region (2027–2032)
Table 21. Global Pharmaceutical Intermediates Revenue by Region (US$ Million), 2021–2026
Table 22. Global Pharmaceutical Intermediates Revenue Market Share by Region (2021–2026)
Table 23. Global Pharmaceutical Intermediates Revenue by Region (US$ Million), 2027–2032
Table 24. Global Pharmaceutical Intermediates Revenue Market Share by Region (2027–2032)
Table 25. North America Pharmaceutical Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Pharmaceutical Intermediates Sales by Country (K MT), 2021–2026
Table 27. North America Pharmaceutical Intermediates Sales by Country (K MT), 2027–2032
Table 28. North America Pharmaceutical Intermediates Revenue by Country (US$ Million), 2021–2026
Table 29. North America Pharmaceutical Intermediates Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Pharmaceutical Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Pharmaceutical Intermediates Sales by Country (K MT), 2021–2026
Table 32. Europe Pharmaceutical Intermediates Sales by Country (K MT), 2027–2032
Table 33. Europe Pharmaceutical Intermediates Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Pharmaceutical Intermediates Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Pharmaceutical Intermediates Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Intermediates Sales by Region (K MT), 2021–2026
Table 37. Asia Pacific Pharmaceutical Intermediates Sales by Region (K MT), 2027–2032
Table 38. Asia Pacific Pharmaceutical Intermediates Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Pharmaceutical Intermediates Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Pharmaceutical Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Pharmaceutical Intermediates Sales by Country (K MT), 2021–2026
Table 42. Latin America Pharmaceutical Intermediates Sales by Country (K MT), 2027–2032
Table 43. Latin America Pharmaceutical Intermediates Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Pharmaceutical Intermediates Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Pharmaceutical Intermediates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Pharmaceutical Intermediates Sales by Country (K MT), 2021–2026
Table 47. Middle East and Africa Pharmaceutical Intermediates Sales by Country (K MT), 2027–2032
Table 48. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (US$ Million), 2027–2032
Table 50. Global Pharmaceutical Intermediates Sales (K MT) by Type (2021–2026)
Table 51. Global Pharmaceutical Intermediates Sales (K MT) by Type (2027–2032)
Table 52. Global Pharmaceutical Intermediates Sales Market Share by Type (2021–2026)
Table 53. Global Pharmaceutical Intermediates Sales Market Share by Type (2027–2032)
Table 54. Global Pharmaceutical Intermediates Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Pharmaceutical Intermediates Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Pharmaceutical Intermediates Revenue Market Share by Type (2021–2026)
Table 57. Global Pharmaceutical Intermediates Revenue Market Share by Type (2027–2032)
Table 58. Global Pharmaceutical Intermediates Price (USD/MT) by Type (2021–2026)
Table 59. Global Pharmaceutical Intermediates Price (USD/MT) by Type (2027–2032)
Table 60. Global Pharmaceutical Intermediates Sales (K MT) by Application (2021–2026)
Table 61. Global Pharmaceutical Intermediates Sales (K MT) by Application (2027–2032)
Table 62. Global Pharmaceutical Intermediates Sales Market Share by Application (2021–2026)
Table 63. Global Pharmaceutical Intermediates Sales Market Share by Application (2027–2032)
Table 64. Global Pharmaceutical Intermediates Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Pharmaceutical Intermediates Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Pharmaceutical Intermediates Revenue Market Share by Application (2021–2026)
Table 67. Global Pharmaceutical Intermediates Revenue Market Share by Application (2027–2032)
Table 68. Global Pharmaceutical Intermediates Price (USD/MT) by Application (2021–2026)
Table 69. Global Pharmaceutical Intermediates Price (USD/MT) by Application (2027–2032)
Table 70. Lonza Company Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 73. Lonza Pharmaceutical Intermediates Product
Table 74. Lonza Recent Developments/Updates
Table 75. Catalent Company Information
Table 76. Catalent Description and Business Overview
Table 77. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 78. Catalent Pharmaceutical Intermediates Product
Table 79. Catalent Recent Developments/Updates
Table 80. Patheon Company Information
Table 81. Patheon Description and Business Overview
Table 82. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 83. Patheon Pharmaceutical Intermediates Product
Table 84. Patheon Recent Developments/Updates
Table 85. Jubilant Company Information
Table 86. Jubilant Description and Business Overview
Table 87. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 88. Jubilant Pharmaceutical Intermediates Product
Table 89. Jubilant Recent Developments/Updates
Table 90. Granules Company Information
Table 91. Granules Description and Business Overview
Table 92. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 93. Granules Pharmaceutical Intermediates Product
Table 94. Granules Recent Developments/Updates
Table 95. Ganesh Company Information
Table 96. Ganesh Description and Business Overview
Table 97. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 98. Ganesh Pharmaceutical Intermediates Product
Table 99. Ganesh Recent Developments/Updates
Table 100. Chemcon Company Information
Table 101. Chemcon Description and Business Overview
Table 102. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 103. Chemcon Pharmaceutical Intermediates Product
Table 104. Chemcon Recent Developments/Updates
Table 105. BASF Company Information
Table 106. BASF Description and Business Overview
Table 107. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 108. BASF Pharmaceutical Intermediates Product
Table 109. BASF Recent Developments/Updates
Table 110. Porton Company Information
Table 111. Porton Description and Business Overview
Table 112. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 113. Porton Pharmaceutical Intermediates Product
Table 114. Porton Recent Developments/Updates
Table 115. Lianhetech Company Information
Table 116. Lianhetech Description and Business Overview
Table 117. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 118. Lianhetech Pharmaceutical Intermediates Product
Table 119. Lianhetech Recent Developments/Updates
Table 120. ABA Chem Company Information
Table 121. ABA Chem Description and Business Overview
Table 122. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 123. ABA Chem Pharmaceutical Intermediates Product
Table 124. ABA Chem Recent Developments/Updates
Table 125. Tianma Company Information
Table 126. Tianma Description and Business Overview
Table 127. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 128. Tianma Pharmaceutical Intermediates Product
Table 129. Tianma Recent Developments/Updates
Table 130. Jiujiujiu Company Information
Table 131. Jiujiujiu Description and Business Overview
Table 132. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 133. Jiujiujiu Pharmaceutical Intermediates Product
Table 134. Jiujiujiu Recent Developments/Updates
Table 135. Alpha Company Information
Table 136. Alpha Description and Business Overview
Table 137. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 138. Alpha Pharmaceutical Intermediates Product
Table 139. Alpha Recent Developments/Updates
Table 140. Jiuzhou Company Information
Table 141. Jiuzhou Description and Business Overview
Table 142. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 143. Jiuzhou Pharmaceutical Intermediates Product
Table 144. Jiuzhou Recent Developments/Updates
Table 145. Yongtai Company Information
Table 146. Yongtai Description and Business Overview
Table 147. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 148. Yongtai Pharmaceutical Intermediates Product
Table 149. Yongtai Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Pharmaceutical Intermediates Distributors List
Table 153. Pharmaceutical Intermediates Customers List
Table 154. Pharmaceutical Intermediates Market Trends
Table 155. Pharmaceutical Intermediates Market Drivers
Table 156. Pharmaceutical Intermediates Market Challenges
Table 157. Pharmaceutical Intermediates Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Intermediates
Figure 2. Global Pharmaceutical Intermediates Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pharmaceutical Intermediates Market Share by Type: 2025 & 2032
Figure 4. GMP Product Picture
Figure 5. Non-GMP Product Picture
Figure 6. Global Pharmaceutical Intermediates Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Pharmaceutical Intermediates Market Share by Application: 2025 & 2032
Figure 8. Antibiotics
Figure 9. Antipyretic Analgesics
Figure 10. Vitamins
Figure 11. Others
Figure 12. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Pharmaceutical Intermediates Market Size (US$ Million), 2021–2032
Figure 14. Global Pharmaceutical Intermediates Sales (K MT), 2021–2032
Figure 15. Global Pharmaceutical Intermediates Average Price (USD/MT), 2021–2032
Figure 16. Pharmaceutical Intermediates Report Years Considered
Figure 17. Pharmaceutical Intermediates Sales Share by Manufacturers in 2025
Figure 18. Global Pharmaceutical Intermediates Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Pharmaceutical Intermediates Players: Market Share by Revenue in Pharmaceutical Intermediates in 2025
Figure 20. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Pharmaceutical Intermediates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Pharmaceutical Intermediates Sales Market Share by Country (2021–2032)
Figure 23. North America Pharmaceutical Intermediates Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Pharmaceutical Intermediates Sales Market Share by Country (2021–2032)
Figure 27. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2021–2032)
Figure 28. Germany Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2021–2032)
Figure 35. China Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2021–2032)
Figure 45. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Pharmaceutical Intermediates Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Pharmaceutical Intermediates by Type (2021–2032)
Figure 55. Global Revenue Market Share of Pharmaceutical Intermediates by Type (2021–2032)
Figure 56. Global Pharmaceutical Intermediates Price (USD/MT) by Type (2021–2032)
Figure 57. Global Sales Market Share of Pharmaceutical Intermediates by Application (2021–2032)
Figure 58. Global Revenue Market Share of Pharmaceutical Intermediates by Application (2021–2032)
Figure 59. Global Pharmaceutical Intermediates Price (USD/MT) by Application (2021–2032)
Figure 60. Pharmaceutical Intermediates Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Pharmaceutical Intermediates in 2026?
The global market size of Pharmaceutical Intermediates in 2026 was 229550 Million USD.
What was the global market size of Pharmaceutical Intermediates in 2032?
Which companies rank high in the global Pharmaceutical Intermediates market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Pharmaceutical Intermediates market size from 2026 to 2032?
Related Reports
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-16
Pages: 173
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-07
Pages: 117
USD 4900.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 143
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 178
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 108
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 172
USD 4900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 147
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-16
Pages: 173
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-07
Pages: 117
USD 4900.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 143
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 178
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 108
USD 4250.00 (Single User License)Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 172
USD 4900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 147
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report